Angiogenesis inhibition causes hypertension and placental dysfunction in a rat model of preeclampsia

Journal of Hypertension

Volumn 27, Issue 4, 2009, Pages 829-837

  Carlström, Mattias ^a,c   Wentzel, Parri ^a   Skøtt, Ole ^b   Persson, A Erik G ^a   Eriksson, Ulf J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Blood pressure; Fetal growth retardation; Pregnancy; Renin; Soluble fms like tyrosine kinase 1; Suramin; Telemetry; Vascular endothelial growth factor

Indexed keywords

RENIN; SURAMIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; HYPERTENSION; NONHUMAN; PLACENTA DISORDER; PLASMA RENIN ACTIVITY; PREECLAMPSIA; PRIORITY JOURNAL; RAT;

EID: 67649646447     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328324f8ce     Document Type: Article

References (44)

1. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38:718-722.
2. Redman CW, Sargent IL. Preeclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 2003; 24 (Suppl A): S21-S27.
3. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222-235.
4. Shah DM. Preeclampsia: new insights. Curr Opin Nephrol Hypertens 2007; 16:213-220.
5. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol 1990; 97:762-769.
6. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet 2000; 45:138-141.
7. Treloar SA, Cooper DW, Brennecke SP, Grehan MM, Martin NG. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol 2001; 184:374-381.
8. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
9. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98:648-655.
10. Myatt L. Role of placenta in preeclampsia. Endocrine 2002; 19:103-111.
11. Alexander BT, Bennett WA, Khalil RA, Granger JP. Preeclampsia: linking placental ischemia with cardiovascular-renal dysfunction. News Physiol Sci 2001; 16:282-286.
12. Luft FC. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a preeclampsia molecule. Nephrol Dial Transplant 2006; 21:3052-3054.
13. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 2004; 145:4835-4837.
14. Kappas NC, Zeng G, Chappell JC, Kearney JB, Hazarika S, Kallianos KG, et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol 2008; 181:847-858.
15. Baird JN Jr. Eclampsia in a lowland gorilla. Am J Obstet Gynecol 1981; 141:345-346.
16. Podjarny E, Baylis C, Losonczy G. Animal models of preeclampsia. Semin Perinatol 1999; 23:2-13.
17. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 2007; 20:686-691.
18. Ianosi-Irimie M, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, et al. A rat model of preeclampsia. Clin Exp Hypertens 2005; 27:605-617.
19. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996; 274:995-998.
20. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:1316-1320.
21. Zhou Y, Chiu K, Brescia RJ, Combs CA, Katz MA, Kitzmiller JL, et al. Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys. Am J Obstet Gynecol 1993; 169:224-229.
22. Gagliardi A, Hadd H, Collins DC. Inhibition of angiogenesis by suramin. Cancer Res 1992; 52:5073-5075.
23. Waltenberger J, Mayr U, Frank H, Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 1996; 28:1523-1529.
24. Nash P, Wentzel P, Lindeberg S, Naessen T, Jansson L, Olovsson M, Eriksson UJ. Placental dysfunction in Suramin-treated rats: a new model for preeclampsia. Placenta 2005; 26:410-418.
25. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 1988; 37:365-374.
26. Carlstrom M, Wahlin N, Sallstrom J, Skott O, Brown R, Persson AE. Hydronephrosis causes salt-sensitive hypertension in rats. J Hypertens 2006; 24:1437-1443.
27. Nash P, Eriksson UJ. Suramin-restricted blood volume in the placenta of normal and diabetic rats is normalized by vitamin E treatment. Placenta 2007; 28:505-515.
28. Nash P, Olovsson M, Eriksson UJ. Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment. J Soc Gynecol Investig 2005; 12:174-184.
29. Young IS. Oxidative stress and vascular disease: insights from isoprostane measurement. Clin Chem 2005; 51:14-15.
30. Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 1999; 43:205-212.
31. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160:1405-1423.
32. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, Baker P. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 1999; 79:1101-1111.
33. Kita N, Mitsushita J. A possible placental factor for preeclampsia: sFlt-1. Curr Med Chem 2008; 15:711-715.
34. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fmslike tyrosine kinase-1 expression. Hypertension 2007; 50:1142-1147.
35. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007; 71:977-984.
36. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
37. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 110 (Suppl 1):S10-S18.
38. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005; 26:210-217.
39. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9:147-160.
40. Anguiano-Robledo L, Reyes-Melchor PA, Bobadilla-Lugo RA, Perez-Alvarez VM, Lopez-Sanchez P. Renal angiotensin-II receptors expression changes in a model of preeclampsia. Hypertens Pregnancy 2007; 26:151-161.
41. Herse F, Staff AC, Hering L, Muller DN, Luft FC, Dechend R. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and preeclampsia. J Mol Med 2008; 86:697-703.
42. Pollock DM. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 2005; 45:477-480.
43. Caluwaerts S, Vercruysse L, Luyten C, Pijnenborg R. Endovascular trophoblast invasion and associated structural changes in uterine spiral arteries of the pregnant rat. Placenta 2005; 26:574-584.
44. Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta 2006; 27:22-33.